SIKs-IN-1 is a salt-inducible kinase (SIKs) inhibitor that suppresses SIK activity, upregulates the anti-inflammatory cytokine IL-10, and downregulates the pro-inflammatory cytokine IL-12; it demonstrates potent anti-inflammatory effects in a DSS-induced colitis model.